Results 191 to 200 of about 200,594 (216)

The diabetes-associated K⁺ channel TALK-2 controls human beta cell endoplasmic reticulum Ca²⁺ handling, which promotes basal insulin release and limits glucose-stimulated insulin secretion. [PDF]

Diabetologia
Dobson JR, Dadi PK, Dickerson MT, Nakhe AY, Behera S, Gibson SE, Peachee SJ, Piron A, Cnop M, Jacobson DA.   +9 more
europepmc   +1 more source

Sensor-Derived Glycemic Metrics in Women with Type 1 Diabetes Using Insulin Degludec Versus Other Basal Insulin Analogs During Pregnancy-A Post Hoc Analysis of the CopenFast Trial. [PDF]

Womens Health Rep (New Rochelle)
Søholm JC, Nørgaard SK, Nørgaard K, Clausen TD, Damm P, Mathiesen ER, Ringholm L.   +6 more
europepmc   +1 more source

Efficacy and Safety of Tirzepatide Compared with GLP-1 RAs in Patients with Type 2 Diabetes Treated with Basal Insulin: A Network Meta-analysis. [PDF]

Diabetes Ther
Osumili B, Sapin H, Yang Z, Ranta K, Paik JS, Blüher M.   +5 more
europepmc   +1 more source

Enhancing Diabetes Treatment: Comparing Pioglitazone/Metformin with Dapagliflozin Versus Basal Insulin/Metformin in Type 2 Diabetes. [PDF]

Drug Des Devel Ther
Lin Y, Shi J, Yu X, Sun J, Lixia S, Dou J, Zhang M, Li X, Tian Z, Deng H, Feng B, Su Q, Peng Y.   +12 more
europepmc   +1 more source

Efficacy and hypoglycaemia outcomes of once-weekly insulin icodec versus once-daily basal insulin comparators across baseline HbA1c, BMI and duration of type 2 diabetes subgroups: A post hoc analysis of ONWARDS 1-5. [PDF]

Diabetes Obes Metab
Cheng AYY, Anil G, Canani L, Vinther S, Wang N, Mathieu C.   +5 more
europepmc   +1 more source

Efficacy of Polyethylene Glycol Loxenatide in Combination with Basal Insulin in Patients with Type 2 Diabetes Mellitus: A Retrospective Real-World Study. [PDF]

Diabetes Ther
Liu X, Zhang Y, Zhao LL, Duan Y, Hu Z, Bao L, Jin P.   +6 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Novel Once-Weekly Basal Insulin Fc Achieved Similar Glycemic Control With a Safety Profile Comparable to Insulin Degludec in Patients With Type 1 Diabetes

Diabetes Care, 2023
Juliana Bue-Valleskey, Emmanuel Chigutsa, Christof M Kazda   +2 more
exaly  

Feasibility of Simplification From a Basal-Bolus Insulin Regimen to a Fixed-Ratio Formulation of Basal Insulin Plus a GLP-1RA or to Basal Insulin Plus an SGLT2 Inhibitor: BEYOND, a Randomized, Pragmatic Trial

Diabetes Care, 2021
Katherine Esposito, Giuseppe Bellastella, Miriam Longo   +2 more
exaly  

Basal weekly insulins: the way of the future!

Metabolism: Clinical and Experimental, 2022
Julio Rosenstock, Stefano Del Prato
exaly  

Initiation of iGlarLixi Versus Basal-Bolus Insulin in Adults With Type 2 Diabetes Advancing From Basal Insulin Therapy: The SoliComplex Real-World Study

Diabetes Spectrum, 2023
Kevin M Pantalone
exaly